The Effect of Ketoconazole or Fluconazole on the Pharmacokinetics of Baricitinib in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 26 Apr 2017
At a glance
- Drugs Baricitinib (Primary) ; Fluconazole; Ketoconazole
- Indications Diabetic nephropathies; Mycoses; Psoriasis; Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 07 Nov 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Nov 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Aug 2013 New trial record